Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Musgrove

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Oncogene|March 20, 1997
Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cellsK J Sweeney, B Sarcevic, R L Sutherland, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1996
Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cellsN R Wilcken, B Sarcevic, E A Musgrove, et al.
Cancer Treatment and Research|January 1, 1996
Cyclins and breast cancerK J Sweeney, E A Musgrove, C K Watts, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonistsR L Sutherland, C S Lee, R S Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogensN R Wilcken, O W Prall, E A Musgrove, et al.
The Journal of Biological Chemistry|September 19, 2000
A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescenceJ S Carroll, O W Prall, E A Musgrove, et al.
Journal of Mammary Gland Biology and Neoplasia|May 20, 2000
Estrogen and progestin regulation of cell cycle progressionR L Sutherland, O W Prall, C K Watts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycleE A Musgrove, C S Lee, M F Buckley, et al.
Oncogene|June 30, 2007
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationC E Caldon, C S L Lee, R L Sutherland, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1997
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21E A Musgrove, C S Lee, A L Cornish, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Oncogene|March 20, 1997
Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cellsK J Sweeney, B Sarcevic, R L Sutherland, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1996
Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cellsN R Wilcken, B Sarcevic, E A Musgrove, et al.
Cancer Treatment and Research|January 1, 1996
Cyclins and breast cancerK J Sweeney, E A Musgrove, C K Watts, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonistsR L Sutherland, C S Lee, R S Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogensN R Wilcken, O W Prall, E A Musgrove, et al.
The Journal of Biological Chemistry|September 19, 2000
A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescenceJ S Carroll, O W Prall, E A Musgrove, et al.
Journal of Mammary Gland Biology and Neoplasia|May 20, 2000
Estrogen and progestin regulation of cell cycle progressionR L Sutherland, O W Prall, C K Watts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycleE A Musgrove, C S Lee, M F Buckley, et al.
Oncogene|June 30, 2007
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiationC E Caldon, C S L Lee, R L Sutherland, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1997
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21E A Musgrove, C S Lee, A L Cornish, et al.
Pageof 7